PharmacyCodes



Fenossibenzamina [Dcit] en es it fr

Fenossibenzamina [Dcit] Brand names, Fenossibenzamina [Dcit] Analogs

Fenossibenzamina [Dcit] Brand Names Mixture

  • No information avaliable

Fenossibenzamina [Dcit] Chemical_Formula

C18H22ClNO

Fenossibenzamina [Dcit] RX_link

http://www.rxlist.com/cgi/generic3/phenoxybenz.htm

Fenossibenzamina [Dcit] fda sheet

Fenossibenzamina [Dcit] msds (material safety sheet)

Fenossibenzamina [Dcit] Synthesis Reference

No information avaliable

Fenossibenzamina [Dcit] Molecular Weight

303.826 g/mol

Fenossibenzamina [Dcit] Melting Point

39 oC

Fenossibenzamina [Dcit] H2O Solubility

No information avaliable

Fenossibenzamina [Dcit] State

Solid

Fenossibenzamina [Dcit] LogP

4.601

Fenossibenzamina [Dcit] Dosage Forms

No information avaliable

Fenossibenzamina [Dcit] Indication

For the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.

Fenossibenzamina [Dcit] Pharmacology

Phenoxybenzamine is indicated for the control of episodes of hypertension and sweating that occur with a disease called pheochromocytoma. If tachycardia is excessive, it may be necessary to use a beta-blocking agent concomitantly. Phenoxybenzamine is a long-acting, adrenergic, alpha-receptor blocking agent which can produce and maintain "chemical sympathectomy" by oral administration. It increases blood flow to the skin, mucosa and abdominal viscera, and lowers both supine and erect blood pressures. It has no effect on the parasympathetic system. Phenoxybenzamine works by blocking alpha receptors in certain parts of the body. Alpha receptors are present in the muscle that lines the walls of blood vessels. When the receptors are blocked by Phenoxybenzamine, the muscle relaxes and the blood vessels widen. This widening of the blood vessels results in a lowering of blood pressure.

Fenossibenzamina [Dcit] Absorption

No information avaliable

Fenossibenzamina [Dcit] side effects and Toxicity

No information avaliable

Fenossibenzamina [Dcit] Patient Information

No information avaliable

Fenossibenzamina [Dcit] Organisms Affected

Humans and other mammals